Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-02

Clinical Trial Update: Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration [NA]

View source ↗

Summary

Clinical trial update indicating repeated injections of aflibercept for wet age-related macular degeneration has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aflibercept (Aflibercept)
  • EYLEA (Aflibercept)

Snippet

Sponsor: MidAtlantic Retina | Conditions: Age-Related Macular Degeneration, Macular Degeneration | NA | Status: COMPLETED | Results posted: 2018-05-02